Amy Lawlor

2PUBLICATIONS
40CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 06, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

|Jun 13, 2023
β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer.

Toshiyasu Suzuki, Anna Kilbey, Nuria Casa-Rodríguez

Pageof 1

Frequent Collaborators

2 joint publications

Philip D Dunne

2 joint publications

Karen Blyth

2 joint publications

Kathryn Gilroy

1 joint publications

Kirsteen J Campbell